CNS Pharmaceuticals, Inc. funding
CNS Pharmaceuticals, Inc., a pharmaceuticals company based in Houston, TX, filed a Form D with the SEC on May 19, 2026 and reported $22.5M raised.
Amount raised$22.5M
Offering size$22.5M
Filed with the SECMay 19, 2026
First saleMay 4, 2026
IndustryPharmaceuticals
SecuritiesEquity, Options or warrants
LocationHouston, TX
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far13
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed May 19
Other health care rounds in Texas
OncoNano Medicine, Inc.$10.1M · Oct 8BiotechnologySolaris Endovascular Inc.$5M · Oct 1BiotechnologyTransformer TX Holdings, LLC$4.1M · Nov 9Hospitals and PhysiciansTeos Health, LLC$3.1M · Oct 30Other Health CareCerenome, Inc.$3M · Sep 18Other Health CareFibroBiologics, Inc.$1.2M · Oct 13PharmaceuticalsPressio, Inc.$544K · Oct 6Other Health CareIctero Medical, Inc.$344K · Nov 5Other Health Care